Based on the company's latest reports for March 2026, the current 12-month EPS is $3.93. Prestige Consumer Healthcare's earnings per share in 2026 was reported at $3.93, marking a decline from $4.32 in 2025. In the quarterly report ending on Mar 31, 2026, PBH's earnings per share amounted to $1.13.
Prestige Consumer Healthcare had an yealy earnings per share of $3.93, showing a decline of 9% from $4.32 recorded in 2025. The quarterly earnings per share for the period ending Mar 31, 2026, was $1.13, showing a 11.9% increase compared to the same quarter last year. The trailing twelve months EPS for PBH is $3.93 as of March 2026. Prestige Consumer Healthcare's full-year EPS for 2025 was $4.32, a 2.6% rise compared to the previous year.
In the past 12 months, Prestige Consumer Healthcare has recorded an earnings per share growth rate of 11.9% (YoY, quarterly). In the last five years, the company had an average annual EPS growth of 3.7%. When assessed over a ten-year period, PBH's average EPS annual growth was 7.6%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| PBH Prestige Consumer Healthcare Inc | 11.57 | -9% | N/A | 3.7% |
| CLX Clorox Co | 14.53 | 190.3% | 20.5% | -2.5% |
| PFE Pfizer Inc | 19.61 | -3.5% | -37.4% | -3.7% |
| PG PROCTER & GAMBLE Co | 20.14 | 7.9% | 3.6% | 5.4% |
| NVS Novartis AG | 21.14 | 21.8% | 31.2% | 15.2% |
| ABT Abbott Laboratories | 25.24 | -51.4% | -1.8% | 8.2% |
| JNJ Johnson & Johnson | 26.13 | 90.6% | 17.7% | 14.8% |
| CVS CVS HEALTH Corp | 40.87 | -61.9% | -24.8% | -23.9% |
All data is based on quarterly TTM periods, unless otherwise specified.